These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2452959

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
    Tomlinson DR, Sidenius P, Larsen JR.
    Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
    [Abstract] [Full Text] [Related]

  • 4. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
    Dahlin LB, Archer DR, McLean WG.
    Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Statil-sensitive polyol formation in nerve of galactose-fed mice.
    Calcutt NA, Willars GB, Tomlinson DR.
    Metabolism; 1988 May; 37(5):450-3. PubMed ID: 3130544
    [Abstract] [Full Text] [Related]

  • 8. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
    Cameron NE, Cotter MA, Robertson S.
    Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
    Price DE, Airey CM, Alani SM, Wales JK.
    Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
    [Abstract] [Full Text] [Related]

  • 11. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
    Stribling D, Mirrlees DJ, Harrison HE, Earl DC.
    Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
    [Abstract] [Full Text] [Related]

  • 12. Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor.
    Tomlinson DR, Townsend J, Fretten P.
    Diabetes; 1985 Oct; 34(10):970-2. PubMed ID: 2412918
    [Abstract] [Full Text] [Related]

  • 13. Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil.
    Kofo-Abayomi A, Lucas PD.
    J Pharm Pharmacol; 1987 Dec; 39(12):1019-21. PubMed ID: 2894428
    [Abstract] [Full Text] [Related]

  • 14. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
    Yasuda H, Sonobe M, Hisanaga T, Kawabata T, Maeda K, Kikkawa R, Shigeta Y.
    Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
    [Abstract] [Full Text] [Related]

  • 15. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR, Moriarty RJ, Mayer JH.
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [Abstract] [Full Text] [Related]

  • 16. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR, Hawthorne JN, Tomlinson DR.
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [Abstract] [Full Text] [Related]

  • 17. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol.
    Mayer JH, Tomlinson DR, McLean WG.
    J Neurochem; 1984 Nov; 43(5):1265-70. PubMed ID: 6208327
    [Abstract] [Full Text] [Related]

  • 18. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. Effects of aldose reductase inhibition.
    Willars GB, Calcutt NA, Compton AM, Tomlinson DR, Keen P.
    J Neurol Sci; 1989 Jun; 91(1-2):153-64. PubMed ID: 2473171
    [Abstract] [Full Text] [Related]

  • 19. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor.
    Naeser P, Brolin SE, Eriksson UJ.
    Metabolism; 1988 Dec; 37(12):1143-5. PubMed ID: 3143049
    [Abstract] [Full Text] [Related]

  • 20. The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat.
    Cameron NE, Leonard MB, Ross IS, Whiting PH.
    Diabetologia; 1986 Mar; 29(3):168-74. PubMed ID: 3084324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.